Leonardo Jaimes is a journalist who covers a wide range of topics in the medical field. With a focus on research and clinical developments, Leonardo's articles provide insights into various diseases, treatments, and breakthroughs. His work aims to inform and educate readers about the latest advancements in healthcare.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Leonardo Jaimes' coverage primarily focuses on scientific and healthcare topics, with an emphasis on citing data. He seems to be interested in the latest medical research findings and developments across various health conditions.
Given his focus on citing data, he is likely to be responsive to pitches from experts who can provide insights based on recent studies or clinical trials related to the specific medical conditions he covers.
Since there is no specified geographic focus, Leonardo's interests seem international in scope. Therefore, sources with a global perspective and expertise in the covered medical conditions may find success when reaching out for potential collaboration.
This information evolves through artificial intelligence and human feedback. Improve this profile .
| Neuromyelitis optica spectrum disorder (NMOSD) could be underdiagnosed in patients with other rheumatologic disorders, according to a
| Patients with neuromyelitis optica spectrum disorder (NMOSD) could benefit from a tailored disability assessment, according to a study recently published in the journal Scientific Reports
Low-density lipoprotein cholesterol (LDL-C) could become a potential biomarker for relapse in patients with neuromyelitis optica spectrum
| Understanding the Philadelphia chromosome subtypes in patients with acute lymphoblastic leukemia (ALL) could guide management strategies
| A simple testing algorithm based on single-cutoff values for red blood cells (RBCs) and platelets could significantly reduce low-yield
| Treatment with tafamidis leads to significant myocardial changes observable with Technetium pyrophosphate ( 99mTc-PYP) scintigraphy in
| Intravenous immunoglobulin (IVIG) maintenance therapy appears to cause clinical improvement in patients with myasthenia gravis (MG), according to a recently published study in the journal Muscle and Nerve
| Neurexin 1 (NRXN1) appeared to be reduced in post-onset Huntington disease (HD) modified mice, and reduced levels of NRXN1 were correlated
| The updated concepts of treatment endpoints and new pharmacological alternatives for patients with hard-to-treat primary biliary
| The Inflammatory Rasch-built Overall Disability Scale (I-RODS) and the Rasch-built Fatigue Severity Scale (R-FSS) appear to be valid
(833) 317-6278 
